Using advanced imaging to study live cancer cells
Official title: Cyclic Immunofluorescent Imaging in Live Cells
Funded at Aperture Bio, INC. · NIH-11069776 · Data updated 2026-11-12
This study is looking at how special imaging tools can help us see live cancer cells in action, which could give us better ideas about how tumors react to different treatments, ultimately helping to tailor therapies for patients like you.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Aperture Bio, INC. NIH-funded |
| Lab location | 1 site (Allston, United States) |
| Project start | March 1, 2025 |
| Project end | February 28, 2026 |
| Funding year | 2025 |
| Award (this year) | $404,994 |
| NIH project number | 1R43CA298597-01 |
| Project ID | NIH-11069776 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are cancer patients undergoing treatment who are interested in understanding how their tumors may respond to therapies.
✕Less likely to help
Patients with non-cancerous conditions or those not currently receiving cancer treatment may not benefit from this research.
What this research studies
This research investigates how advanced imaging techniques can be applied to live cancer cells to better understand their behavior and interactions. By utilizing a unique platform, the study aims to capture dynamic cellular functions and biological processes in real-time, which could help predict how tumors respond to various therapies. The approach focuses on analyzing the tumor microenvironment and its impact on treatment efficacy, potentially leading to improved precision medicine strategies. Patients may benefit from insights gained about their specific cancer types and treatment responses.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective cancer treatments based on individual tumor characteristics.
How similar studies have gone: Other research has shown promise in using advanced imaging techniques for cancer studies, indicating a potential for success in this novel approach.
Where this research is happening
-
Aperture Bio, INC.
Allston, United States Active
Researchers
- Principal investigator: Peterson, Hannah Marie — Aperture Bio, INC.
- Study coordinator: Peterson, Hannah Marie
Related research
Other NIH-funded projects on the same topics.
-
Fast single-cell protein test to help guide cancer treatment
A company is developing a quick test that reads proteins in individual tumor and immune cells to help doctors pick better treatments for people with cancer.
-
Developing a new tool for analyzing cancer cells to improve treatment selection
This study is working on a new tool that looks closely at individual cancer cells to help doctors better understand which patients might benefit from the latest cancer treatments, making it easier for more clinics to use.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.